Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837499 · ClinicalTrials.gov registry record
Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.
A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 938
- Enrollment target
- 7
- Study locations
NCT00837499: Completed study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00837499 is a study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 938 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (67% lower). The trial reports 7 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837499, a study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 938 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this epidemiologic research study is to find out if various risk factors and certain markers (substances that help identify the presence of cancer) that help predict increased occurrence and prognosis (outcome of disease) of breast cancer differ among Mexican, Mexican-American, and African-American women.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (7)
Texas
- LBJ Hospital - Houston
- University of Texas MD Anderson Cancer Center - Houston
- The Rose Diagnostic Center - Houston
Other
- Instituto Tecnologico - Ciudad Obregón
- University of Guadalajara - Guadalajara
Arizona
- Arizona Cancer Center - Tucson
Sonora
- University of Sonora - Hermosillo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 938 participants |
| Start Date | 2007-01-01 |
| Est. Completion | 2021-05-10 |
What the finished NCT00837499 record still lists
NCT00837499 is an observational study that tracks outcomes without assigning an intervention. The registered 938 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00837499 lists 7 locations in 4 states (Texas, Other, Arizona).
Frequently Asked Questions
What is clinical trial NCT00837499 about?
NCT00837499 is a clinical study titled "Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.". The goal of this epidemiologic research study is to find out if various risk factors and certain markers (substances that help identify the presence of cancer) that help predict increased occurrence and prognosis (outcome of disease) of breast cancer differ among Mexican, Mexican-American, and Afric...
What is the current status of trial NCT00837499?
This trial is currently completed. The enrollment target is 938 participants. The study started on 2007-01-01. Estimated completion is 2021-05-10.
What conditions does trial NCT00837499 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00837499?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00837499?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00837499 being conducted?
This trial has 7 study locations across Arizona, Texas, Sonora. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00837499's enrollment target sits among peer trials
938 131st of 1224 higher than 1,094 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT05519007 · 936 participants · NA
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
- NCT06808334 · 942 participants
CLAiR Pivotal Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI